Camden National Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
116,112
-3,237
-3% -$310K 1.36% 29
2025
Q4
$11.5M Buy
119,349
+251
+0.2% +$24.4K 1.58% 25
2025
Q3
$11.3M Sell
119,098
-1,066
-0.9% -$98K 1.59% 24
2025
Q2
$10.5M Sell
120,164
-2,051
-2% -$174K 1.51% 26
2025
Q1
$11M Sell
122,215
-2,541
-2% -$227K 1.63% 21
2024
Q4
$9.97M Sell
124,756
-2,552
-2% -$221K 1.49% 27
2024
Q3
$11.5M Sell
127,308
-5,718
-4% -$481K 1.64% 24
2024
Q2
$10.5M Buy
133,026
+15,638
+13% +$1.28M 1.62% 25
2024
Q1
$10.2M Sell
117,388
-2,666
-2% -$228K 1.81% 18
2023
Q4
$9.89M Buy
120,054
+59,625
+99% +$4.54M 1.84% 17
2023
Q3
$4.74M Buy
60,429
+203
+0.3% +$17K 0.97% 51
2023
Q2
$5.31M Sell
60,226
-182
-0.3% -$15.7K 1.04% 46
2023
Q1
$4.87M Buy
60,408
+2,695
+5% +$220K 0.99% 46
2022
Q4
$4.49M Sell
57,713
-2,867
-5% -$232K 0.94% 49
2022
Q3
$4.89M Buy
60,580
+176
+0.3% +$15.8K 1.09% 44
2022
Q2
$5.42M Buy
60,404
+1,764
+3% +$179K 1.12% 49
2022
Q1
$6.51M Buy
58,640
+978
+2% +$103K 1.18% 43
2021
Q4
$5.96M Sell
57,662
-380
-0.7% -$44K 1.05% 41
2021
Q3
$7.28M Buy
58,042
+26
+0% +$3.37K 1.4% 34
2021
Q2
$7.2M Sell
58,016
-1,700
-3% -$213K 1.36% 33
2021
Q1
$7.05M Sell
59,716
-1,512
-2% -$177K 1.41% 31
2020
Q4
$7.17M Sell
61,228
-3,175
-5% -$350K 1.49% 27
2020
Q3
$6.69M Buy
64,403
+1,039
+2% +$104K 1.48% 27
2020
Q2
$5.81M Buy
63,364
+475
+0.8% +$45.5K 1.44% 29
2020
Q1
$5.67M Sell
62,889
-7,729
-11% -$822K 1.54% 31
2019
Q4
$8.01M Buy
70,618
+1,215
+2% +$133K 1.62% 33
2019
Q3
$7.54M Buy
69,403
+1,202
+2% +$125K 1.64% 34
2019
Q2
$6.64M Buy
68,201
+3,800
+6% +$347K 1.53% 36
2019
Q1
$5.87M Buy
64,401
+3,178
+5% +$284K 1.42% 39
2018
Q4
$5.57M Buy
61,223
+2,271
+4% +$212K 1.53% 36
2018
Q3
$5.8M Buy
58,952
+2,227
+4% +$206K 1.43% 39
2018
Q2
$4.86M Buy
56,725
+7,101
+14% +$593K 1.28% 41
2018
Q1
$3.98M Buy
+49,624
New +$4.09M 1.15% 39

Other funds holding MDT

Camden National Bank's MDT Position: Q1 2026 in Review

Camden National Bank reduced its Medtronic (MDT) stake by 2.7% in Q1 2026, selling an estimated $310K and leaving 116,112 shares worth $10.1M. The position accounts for 1.36% of the portfolio, ranked #29.

Camden National Bank first reported a position in MDT in Q1 2018 and has held it in 33 quarters since. The position peaked at $11.5M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Camden National Bank held 116,112 shares of Medtronic worth $10.1M as of Q1 2026.
  • Camden National Bank sold 3,237 Medtronic shares in Q1 2026, an estimated $310K.
  • Medtronic made up 1.36% of Camden National Bank's portfolio in Q1 2026, its #29 holding.
  • Camden National Bank first reported a position in Medtronic in Q1 2018 and has held it in 33 quarters since.
  • Camden National Bank's Medtronic position peaked at $11.5M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Camden National Bank's 13F filing for Q1 2026, filed 4 May 2026.